The store will not work correctly when cookies are disabled.
(E)-2-(2-(5,6-Dihydro-7H-cyclopenta[b]pyridin-7-ylidene)-hydrazinyl)benzo[d]thiazole
ID: ALA4785055
PubChem CID: 162666687
Max Phase: Preclinical
Molecular Formula: C15H12N4S
Molecular Weight: 280.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cnc2c(c1)CC/C2=N\Nc1nc2ccccc2s1
Standard InChI: InChI=1S/C15H12N4S/c1-2-6-13-11(5-1)17-15(20-13)19-18-12-8-7-10-4-3-9-16-14(10)12/h1-6,9H,7-8H2,(H,17,19)/b18-12+
Standard InChI Key: QPWOORSXXPGRNW-LDADJPATSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
13.6705 -10.1443 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.3402 -9.4012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9467 -8.8492 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6558 -9.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4850 -10.0603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0915 -10.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8687 -10.3535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0395 -9.5551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4289 -9.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5418 -9.2304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9940 -9.8369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5850 -10.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8800 -9.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1709 -10.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1709 -11.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8800 -11.4398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5850 -11.0312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0467 -9.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8612 -8.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1915 -9.6661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
5 6 2 0
10 11 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
18 19 1 0
19 20 1 0
12 20 1 0
13 18 1 0
11 20 2 0
2 10 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.36 | Molecular Weight (Monoisotopic): 280.0783 | AlogP: 3.45 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.17 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.22 | CX Basic pKa: 3.31 | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.73 | Np Likeness Score: -1.62 |
References
1. Chen G,Niu C,Yi J,Sun L,Cao H,Fang Y,Jin T,Li Y,Lou C,Kang J,Wei W,Zhu J. (2019) Novel Triapine Derivative Induces Copper-Dependent Cell Death in Hematopoietic Cancers., 62 (6.0): [PMID:30835473] [10.1021/acs.jmedchem.8b01996] |